In the biotech space, Cell and Gene Therapy and Clean Meat are two of the most promising industries. Yet both are facing the same issue: large-scale cell culture remains the blocking point to scale up and make both Cell and Gene Therapies and Clean Meat accessible and affordable. To that end, Kolibri is building a proprietary cell-engineering platform, combining cutting-edge techniques in acoustics and biology, allowing for a 90x higher yield while decreasing production costs up to 50x.